Saint Joseph's University: Study Examines the Benefits of Using Medical Marijuana to Treat Opioid Addiction
May 08, 2020
May 08, 2020
PHILADELPHIA, Pennsylvania, May 8 [TNSmedicalresearch] -- Saint Joseph's University issued the following news:
Research on marijuana's use in medicine is limited because it is classified as a Schedule 1 drug by the U.S. government, meaning it is considered to have no use in treatment of disease and has a high potential for abuse. But a recent study co-authored by the members of the Opioid Task Force at Saint Joseph's Institute of Clinical Bioethics explores the need to expand this r . . .
Research on marijuana's use in medicine is limited because it is classified as a Schedule 1 drug by the U.S. government, meaning it is considered to have no use in treatment of disease and has a high potential for abuse. But a recent study co-authored by the members of the Opioid Task Force at Saint Joseph's Institute of Clinical Bioethics explores the need to expand this r . . .